As decision on new Alzheimer's drug nears, Biogen aims for redemption; Codeveloped with Japan's Eisai, the novel therapy for the debilitating brain disease could be approved this week.

Press/Media

Period2 Jan 2023

Media coverage

2

Media coverage

  • TitleAs decision on new Alzheimer's drug nears, Biogen aims for redemption; Codeveloped with Japan's Eisai, the novel therapy for the debilitating brain disease could be approved this week.
    Media name/outletbostonglobe.com
    Country/TerritoryUnited States
    Date2/01/23
    PersonsSamuel Gandy
  • TitleFDA decision on Alzheimer's drug has wide ramifications; Codeveloped with Japan's Eisai, the novel therapy for the debilitating brain disease could be approved this week.
    Media name/outletThe Boston Globe
    Country/TerritoryUnited States
    Date2/01/23
    PersonsSamuel Gandy